CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$1.32
-0.01 (-0.75%)
As of Apr 1, 3:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
70.84M
Net Income
-75,634,132
Gross Margin
72.4%
Profit Margin
-106.8%
Rev Growth
+36.5%
D/E Ratio
4.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 72.4% 72.4% 53.6% 53.6%
Operating Margin -77.9% -70.2% 20.6% 21.3%
Profit Margin -106.8% -101.4% 22.1% 19.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 70.84M 51.91M 10.25M 10.35M
Gross Profit 51.26M 37.56M 5.50M 5.55M
Operating Income -55,218,223 -36,415,622 2.11M 2.20M
Net Income -75,634,132 -49,879,621 2.27M 1.98M
Gross Margin 72.4% 72.4% 53.6% 53.6%
Operating Margin -77.9% -70.2% 20.6% 21.3%
Profit Margin -106.8% -101.4% 22.1% 19.1%
Rev Growth +36.5% +36.5% +24.9% +1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 14.29M 14.29M 12.27M 11.63M
Total Equity 3.01M 3.01M 14.31M 15.01M
D/E Ratio 4.75 4.75 0.86 0.77
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -65,592,862 -45,660,745 3.06M 3.48M
Free Cash Flow 1.07M 1.08M